SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-036928
Filing Date
2020-11-13
Accepted
2020-11-13 16:15:23
Documents
45
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0920_aikidopharma.htm 10-Q 469655
2 CERTIFICATION f10q0920ex31-1_aikido.htm EX-31.1 15931
3 CERTIFICATION f10q0920ex32-1_aikido.htm EX-32.1 6973
  Complete submission text file 0001213900-20-036928.txt   2151297

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE aiki-20200930.xml EX-101.INS 265079
5 XBRL SCHEMA FILE aiki-20200930.xsd EX-101.SCH 43363
6 XBRL CALCULATION FILE aiki-20200930_cal.xml EX-101.CAL 35999
7 XBRL DEFINITION FILE aiki-20200930_def.xml EX-101.DEF 96360
8 XBRL LABEL FILE aiki-20200930_lab.xml EX-101.LAB 241519
9 XBRL PRESENTATION FILE aiki-20200930_pre.xml EX-101.PRE 159414
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
Aikido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-05576 | Film No.: 201311663
SIC: 8731 Services-Commercial Physical & Biological Research